Table of Content



1. Executive Summary

2. Global Dysmenorrhea Treatment Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges?

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Dysmenorrhea Treatment Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Dysmenorrhea Treatment Market by Treatment Type
3.3.1: Non-Steroidal Anti-Inflammatory Drugs
3.3.2: Hormonal Therapy

3.4: Global Dysmenorrhea Treatment Market by Type
3.4.1: Primary Dysmenorrhea
3.4.2: Secondary Dysmenorrhea

3.5: Global Dysmenorrhea Treatment Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Research Center




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Dysmenorrhea Treatment Market by Region
4.2: North American Dysmenorrhea Treatment Market
4.2.1: North American Dysmenorrhea Treatment Market by Treatment Type: Non-Steroidal Anti-Inflammatory Drugs and Hormonal Therapy
4.2.2: North American Dysmenorrhea Treatment Market by End Use: Hospitals & Clinics and Research Center

4.3: European Dysmenorrhea Treatment Market
4.3.1: European Dysmenorrhea Treatment Market by Treatment Type: Non-Steroidal Anti-Inflammatory Drugs and Hormonal Therapy
4.3.2: European Dysmenorrhea Treatment Market by End Use: Hospitals & Clinics and Research Center

4.4: APAC Dysmenorrhea Treatment Market
4.4.1: APAC Dysmenorrhea Treatment Market by Treatment Type: Non-Steroidal Anti-Inflammatory Drugs and Hormonal Therapy
4.4.2: APAC Dysmenorrhea Treatment Market by End Use: Hospitals & Clinics and Research Center

4.5: ROW Dysmenorrhea Treatment Market
4.5.1: ROW Dysmenorrhea Treatment Market by Treatment Type: Non-Steroidal Anti-Inflammatory Drugs and Hormonal Therapy
4.5.2: ROW Dysmenorrhea Treatment Market by End Use: Hospitals & Clinics and Research Center

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Dysmenorrhea Treatment Market by Treatment Type
6.1.2: Growth Opportunities for the Global Dysmenorrhea Treatment Market by Type
6.1.3: Growth Opportunities for the Global Dysmenorrhea Treatment Market by End Use
6.1.4: Growth Opportunities for the Global Dysmenorrhea Treatment Market by Region

6.2: Emerging Trends in the Global Dysmenorrhea Treatment Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Dysmenorrhea Treatment Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dysmenorrhea Treatment Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Novartis
7.2: Bayer
7.3: Abbott Laboratories
7.4: F. Hoffmann-La Roche
7.5: Sanofi
7.6: Pfizer
7.7: GlaxoSmithKline
7.8: Focus Consumer Healthcare
7.9: Johnson & Johnson
7.10: Alvogen